MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Pacing Over the Wire in Minimalistic TAVI
A review of the LV pacing technique in four steps, special considerations, and materials required.
By Mauro Boiago, MD, and Nicolas Dumonteil, MD
Abbott’s Tendyne TMVI System Receives CE Mark Approval
January 30, 2020—Abbott announced that its Tendyne transcatheter mitral valve implantation (TMVI) system received European CE Mark approval for the treatment of significant mitral regurgitation (MR) in patients requiring a heart valve replacement who are not candidates for open heart surgery or transcatheter mitral valve repair.
Keystone Heart's TriGuard 3 Cerebral Embolic Protection Device Receives CE Mark Approval for Use in Transcatheter Heart Procedures
March 10, 2020—Keystone Heart Ltd., a Venus Medtech Company, announced European CE Mark approval for the TriGuard 3 cerebral embolic protection device, which is designed to cover and protect all three major cerebral aortic arch vessels during transcatheter aortic valve replacement (TAVR) and other transcatheter heart procedures.
Shared Technical Mastery
By Azeem Latib, MD, and Manaf Assafin, MD
Electroducer Sleeve for Direct-Wire Pacing During Cardiac Interventions Evaluated in Pilot Study
December 15, 2022—Electroducer, which is a Grenoble, France-based medical device developer focused on the treatment of heart diseases, announced the results from the pilot study of the company’s Electroducer Sleeve for use in endovascular procedures requiring temporary cardiac pacing.
GE HealthCare’s Allia IGS Pulse Receives FDA Clearance for Cardiac Imaging
October 16, 2023—GE HealthCare announced FDA 510(k) clearance of the latest addition to the company’s image guided system (IGS) portfolio—Allia IGS Pulse, which features a new imaging chain engineered to provide imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size.
